Prescription drug misuse and illicit drug abuse are growing public health challenges worldwide. Building a test profile that covers highly misused drugs has never been so vital. The Abbott reagent portfolio allows easy screening for relevant substances. Our complete line of assays, calibrators, and controls enables implementation of an efficient drug testing system.
We offer the following reagent formats for multiple matrices: HEIA™, SEFRIA™ and ELISA.
Our comprehensive reagent menu includes illicit compounds, opiates, opioids, synthetic cannabinoids and other drugs.
SEFRIA reagents comprise the next generation immunoassay utilizing β-galactosidase enzyme allowing for lower cutoffs, wider assay span and enhanced precision in a ready-to-use liquid format.
HEIA (homogeneous enzyme immunoassay) reagents are intended for the qualitative or semi-quantitative screening of drugs in human urine and oral fluid. HEIA formats are designed to be rapid and inexpensive, since the assays require no incubation or separation steps, and the reactions occur entirely in solution.
Enzyme Linked Immunosorbent Assay (ELISA) screening techniques are widely utilized by toxicologists to screen forensic specimens for drugs of abuse. These immunoassays are extremely flexible and have adequate sensitivity to go down to the drug levels found in most forensic matrices.
Quality products with the accuracy, reliability and confidence you expect.
Based on your current location, the content on this page may not be relevant for your country.
